p21, a downstream target gene of p53, was also significantly upregulated, which further decreased the expression of CCNB1-CDC2, leading to G2/M phase cell cycle arrest, thereby inhibiting tumor cell proliferation (Uzor et al., 2021; Chen et al., 2022). Here, CCNB1 is linked to neoplasm.